AstraZeneca PLC (AZN.L) EBITDA

Price: $11316
Market Cap: $175.47B
Avg Volume: 2.74M
Country: GB
Industry: Drug Manufacturers - General
Sector: Healthcare
Beta: 0.157
52W Range: $9670-13388
Website: AstraZeneca PLC

What is AstraZeneca PLC's EBITDA?

  • AstraZeneca PLC's annual EBITDA is $17.12B.
  • AstraZeneca PLC's quarterly EBITDA is $4.43B.

What is EBITDA?

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances.

How is EBITDA calculated?

EBITDA is calculated using the following formula:

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Related Metrics

Other important metrics to assess AstraZeneca PLC's financial health include:

  • EBITDA Ratio - measures the company's EBITDA as a percentage of its revenue:
    • Annual: 31.66%
    • Quarterly: 29.76%
  • Growth EBITDA - measures the annual growth rate of the company's EBITDA:
    • Annual: 23.07%
    • Quarterly: 8.04%
  • Growth EBITDA Ratio - measures the annual growth rate of the company's EBITDA ratio:
    • Annual: 4.26%
    • Quarterly: -1.58%

These metrics provide insights into AstraZeneca PLC's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual EBITDA

$17.12B

Quarterly EBITDA

$4.43B

AstraZeneca PLC Historical EBITDA
EBITDA (Annual)
EBITDA (Quarterly)
$20.00B$20.00B$16.00B$16.00B$12.00B$12.00B$8.00B$8.00B$4.00B$4.00B$0.00$0.00EBITDA201620162017201720182018201920192020202020212021202220222023202320242024
Historical EBITDA Ratio (Annual)
32.44%32.44%25.95%25.95%19.46%19.46%12.97%12.97%6.49%6.49%0.00%0.00%EBITDA Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical EBITDA Ratio (Quarterly)
45.57%45.57%35.96%35.96%26.34%26.34%16.73%16.73%7.12%7.12%-2.50%-2.50%EBITDA Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025

AstraZeneca PLC Historical EBITDA Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year EBITDA Growth EBITDA EBITDA Ratio Growth EBITDA Ratio
2024 $17.12B 23.07% 31.66% 4.26%
2023 $13.91B 53.13% 30.37% 44.40%
2022 $9.09B 77.68% 21.03% 4.02%
2021 $5.11B -36.75% 20.22% -35.71%
2020 $8.08B 20.44% 31.45% 9.30%
2019 $6.71B -5.62% 28.77% -11.29%
2018 $7.11B 7.38% 32.44% 7.62%
2017 $6.62B -8.97% 30.14% -4.94%
2016 $7.28B 4.54% 31.71% 11.98%
2015 $6.96B 26.75% 28.31% 34.56%

Related Metrics

Explore detailed financial metrics and analysis for AZN.L.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio